Background

The Kingdom of Saudi Arabia is considered among the top countries with high obesity prevalence. To fight this problem, the government has established governmentally-funded centers for the surgical and medical management of obesity and its comorbid conditions. The Bariatric Center at King Fahad Specialist Hospital in Buraydah is the only governmental center for the surgical of obesity in the entire Qassim region.

Methods

A retrospective study of 77 patients who continued to follow up with the surgical team after they underwent sleeve gastrectomy at the Bariatric Center of King Fahad Specialist Hospital in Buraydah between January 2017 and December 2018. Data were collected from patients' files then analyzed using IBM SPSS. The research is still ongoing and more data analysis will be carried for other data collected from those patients. Also, data will be added from patient who underwent sleeve gastrectomy between January 2019 and March 2020.

Results

In compression with the pre-surgical values, the following was noted; the HDL levels after 6, 12, 24 months showed an increase by 0.12, 0.53, 0.35 mmol/L. The LDL decreased by 0.52, 0.77, and 0.73 mmol/L after 6, 12, and 24 months respectively. Regarding the fasting blood glucose, it decreased by 0.92, 1.21, and 0.97 mmol/L after 6, 12, and 24 months respectively. In diabetics, the HbA1c levels decreased by 1.68, 2.13, and 2.27 after 6, 12, and 24 months respectively.

Conclusions

SG can reduce the diabetic complications and the risks for cardiovascular conditions by increasing HDL, and lowering LDL and HbA1c.